semaglutide vs tirzepatide effectiveness and liraglutide for weight loss in patients with overweight or obesity without diabetes: A short-term cost-effectiveness analysis in the United States Semaglutide vs. Tirzepatide: Which Weight

Tirzepatide is a dual-agonist that stimulates glucagon production by mimicking glucose-dependent insulinotropic polypeptide (GIP) hormones in addition to GLP-1 hormones

The Lilly savings card is not usable by Medicare or Medicaid beneficiaries

Being overweight or obese is a serious health problem connected with some leading causes of death, including diabetes, stroke, and heart disease, and is associated with an increased risk of certain types of cancer

Research involving multiple metabolic-, mitochondrial-, or stimulant-related compounds may warrant additional caution and individualized evaluation in experimental settings